ArticleJournal for immunotherapy of cancer2025

ADI-270: an armored allogeneic gamma delta T cell therapy designed to target CD70-expressing solid and hematologic malignancies.

Kevin P Nishimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.